The goal of this observational cohort study is to learn how toxin and occupational exposures, germline genetic variation, and immune dysregulation relate to B-…

Non-Hodgkin LymphomaLymphoma Non-HodgkinB-cell Lymphoma+1 more

~Estimated

~$10 – $750

Henry M. Jackson Foundation for the Advancement of Military MedicineNCT07652580

Phase 2

Epcoritamab in Combination With R-CHOP Debulking in Newly Diagnosed Patients With Aggressive Non-Hodgkin Lymphoma

A Phase II, open-label, two-arm, multicenter study evaluating the combination of epcoritamab with R-CHOP chemotherapy in patients with newly diagnosed, aggress…

Non-Hodgkin's B-cell LymphomaLymphoma Non-HodgkinDiffuse Large B-Cell Lymphoma (DLBCL)

~Estimated

~$10 – $7,500

Carrie Ho, MDNCT07588698